Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21788559

Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 Aug 20
First author
Prébet T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Prébet T
      type
      Author
    2. name
      Gore SD
      type
      Author
    3. name
      Esterni B
      type
      Author
    4. name
      Gardin C
      type
      Author
    5. name
      Itzykson R
      type
      Author
    6. name
      Thepot S
      type
      Author
    7. name
      Dreyfus F
      type
      Author
    8. name
      Rauzy OB
      type
      Author
    9. name
      Recher C
      type
      Author
    10. name
      Adès L
      type
      Author
    11. name
      Quesnel B
      type
      Author
    12. name
      Beach CL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Prébet T
      type
      Author
    2. name
      Gore SD
      type
      Author
    3. name
      Esterni B
      type
      Author
    4. name
      Gardin C
      type
      Author
    5. name
      Itzykson R
      type
      Author
    6. name
      Thepot S
      type
      Author
    7. name
      Dreyfus F
      type
      Author
    8. name
      Rauzy OB
      type
      Author
    9. name
      Recher C
      type
      Author
    10. name
      Adès L
      type
      Author
    11. name
      Quesnel B
      type
      Author
    12. name
      Beach CL
      type
      Author
    bibliography ids
    1. nci-bib-d13e63eb231c61b83241edc1
    book metadata
    content sha256
    df4fc6abb11b1f90876005da75f0cc300de4983c840dc537b677f2096345b661
    document type
    citation
    dois
    1. 10.1200/JCO.2011.35.8135
    electronic publication date
    display
    2011 Jul 25
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21788559
    immutable id
    pubmed:21788559@df4fc6abb11b1f90876005da75f0cc300de4983c840dc537b677f2096345b661
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    24
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3322-7
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21788559
      provenance
      batch id
      2529ef2eca926738ab13
      provider
      NCBI PubMed ESummary
      record sha256
      a3e844f4ef3b899715f4b18ccdccb437db8d69fd9420315a2037349cc444ff7a
      response sha256
      9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
      retrieved at
      2026-09-09T23:46:42.856296+00:00
      publication date
      display
      2011 Aug 20
      precision
      day
      year
      2011
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21788559/
      title
      Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.

      Preserved source evidence · Not medical advice